Patent details

Basic Information

Publication number:

92565

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP057466096

Legal Status:

Active

Application number:

92565

First applicant's nationality:

Procedural language:

French

Marketing Authorization

Marketing Authorization Number:

EU/1/14/922/001-003 Incruse-bromure d'umeclidinium

Marketing Authorization Type:

Marketing Authorization Date:

30/04/2014

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Luxembourg (LU)

Dates

Filing date:

02/10/2014

First Marketing Authorization date:

30/04/2014

Grant date:

02/12/2014

Activation date:

27/04/2025

Publication date:

02/12/2014

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

30/04/2029

SPC Extension Expiration:

30/04/2029

Rejection date:

Withdrawal date:

Owner

From:

16/04/2025

 

 

Name:

GLAXO GROUP LIMITED

Address:

GSK Medicines Research Centre; Gunnels Wood Road, SG1 2NY, Stevenage, United Kingdom (GB)

History of Owners

From:

02/10/2014

To:

16/04/2025

Name:

Glaxo Group Limited

Address:

980 Great West Road, Brentford, Middlesex TW8 9GS, United Kingdom (GB)

Agent

Name:

KIRKPATRICK

From:

02/10/2014

Address:

AVENUE WOLFERS 32, 1310, LA HULPE, Belgium (BE)

To:

Inventor

1

Name:

NEIPP Christopher, E.

Address:

United States (US)

2

Name:

PALOVICH Michael, R.

Address:

United States (US)

3

Name:

MCCLELAND Brent, W.

Address:

United States (US)

4

Name:

THOMAS Sonia, M.

Address:

United States (US)

5

Name:

LAINE Dramane, I.

Address:

United States (US)

Publication

Bulletin

1

Bulletin Heading:

SPC4

Bulletin edition number:

2019/02

Publication date:

22/02/2019

Description:

Section F : Correction of granted supplementary protection certificates – I9 publication

2

Bulletin Heading:

SPC3

Bulletin edition number:

2025/06

Publication date:

12/05/2025

Description:

Section E : Supplementary Protection certificates entered into force – IA publication

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of owner(s) name/address

Deed Number:

RC20250000122A

Date Registered:

16/04/2025

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

ARONOVA S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

GLAXO GROUP LIMITED

Address:

GSK Medicines Research Centre; Gunnels Wood Road, SG1 2NY, Stevenage, United Kingdom (GB)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

30/04/2026

Annual Fee Number:

22

Annual Fee Amount:

420 Euro

Expected Payer:

Last Annual Fee Payment Date:

19/03/2025

Last Annual Fee Paid Number:

21

Last Annual Fee Paid Amount:

410 Euro

Payer:

ANAQUA SERVICES (ANC. SGA2)

Filing date	Document type	Number of pages
17/01/2019	Publication	1
22/09/2016	Incoming Correspondence (Post)	11
01/09/2016	Incoming Correspondence (Post)	11
17/01/2019	Outgoing Correspondence	1
16/04/2025	Request For Change	3
12/05/2025	Outgoing Correspondence	2
17/04/2025	General Document	2